Close Menu

Oxford Nanopore's announcement of its new whole-genome sequencing technology has set the genomics world talking once again about the $1,000 genome and how it could change research and healthcare. It "has the promise of taking the enterprise of sequencing an individual's genome out of the basic science laboratory, and out to the consumer mass market," says Razib Khan at The Crux blog.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

In a letter, about two dozen researchers criticize the World Health Organization investigation into the origins of SARS-CoV-2 and call for a new inquiry, the Wall Street Journal reports.

National Geographic reports that nine great apes at the San Diego Zoo have been vaccinated against SARS-CoV-2.

Janet Woodcock, the acting commissioner of the US Food and Drug Administration, speaks with NPR about SARS-CoV-2 testing and vaccines in the US.

In Science this week: genetic study of kidney fibrosis implicates the SOX9-NAV3-YAP1 axis.